A visual guide to vaccines for the routine vaccination programme
Updated 13 December 2023
Vaccines used in the UK routine immunisation schedule
Vaccine trade name, manufacturer, abbreviation | Disease(s) protected against | Age due |
---|---|---|
Infanrix hexa (GSK) or Vaxelis (Sanofi Pasteur) Hexavalent vaccine DTaP/IPV/Hib/HepB | Diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type b (Hib) and hepatitis B | 8, 12 and 16 weeks |
Vaccine trade name, manufacturer, abbreviation | Disease(s) protected against | Age due |
---|---|---|
Prevenar 13 (Pfizer) PCV | Pneumococcal (13 serotypes) | 12 weeks and 1 year |
Vaccine trade name, manufacturer, abbreviation | Disease(s) protected against | Age due |
---|---|---|
Bexsero (GSK) MenB | Meningococcal group B | 8 weeks, 16 weeks and 1 year |
Vaccine trade name, manufacturer, abbreviation | Disease(s) protected against | Age due |
---|---|---|
Rotarix (GSK) Rotavirus (oral) | Rotavirus gastroenteritis | 8 weeks and 12 weeks |
Vaccine trade name, manufacturer, abbreviation | Disease(s) protected against | Age due |
---|---|---|
Menitorix (GSK) Hib/MenC | Haemophilus influenzae type b (Hib) and meningococcal group C | 1 year |
Vaccine trade name, manufacturer, abbreviation | Disease(s) protected against | Age due |
---|---|---|
MMRvaxPro (MSD) or Priorix (GSK) MMR | Measles, mumps and rubella | 1 year and 3 years 4 months |
Vaccine trade name, manufacturer, abbreviation | Disease(s) protected against | Age due |
---|---|---|
Fluenz Tetra (AstraZeneca) LAIV (nasal) | Influenza | Eligible paediatric age groups [footnote 1] |
Vaccine trade name, manufacturer, abbreviation | Disease(s) protected against | Age due |
---|---|---|
Boostrix-IPV (GSK) dTaP/IPV | Diphtheria, tetanus, pertussis and polio | 3 years 4 months; and pregnant women from 16 weeks gestation |
Vaccine trade name, manufacturer, abbreviation | Disease(s) protected against | Age due |
---|---|---|
Gardasil 9 (MSD) HPV | Cancers and genital warts caused by specific human papillomavirus (HPV) types | Boys and girls aged 12 to 13 years (school Year 8) |
Vaccine trade name, manufacturer, abbreviation | Disease(s) protected against | Age due |
---|---|---|
Revaxis (Sanofi Pasteur) Td/IPV | Tetanus, diphtheria and polio | 14 years (school Year 9) |
Vaccine trade name, manufacturer, abbreviation | Disease(s) protected against | Age due |
---|---|---|
Nimenrix (Pfizer) MenACWY | Meningococcal groups A, C, W and Y | 14 years (school Year 9) |
Vaccine trade name, manufacturer, abbreviation | Disease(s) protected against | Age due |
---|---|---|
Pneumovax 23 (MSD) PPV | Pneumococcal (23 serotypes) | 65 years (and certain at-risk groups) [footnote 2] |
Vaccine trade name, manufacturer, abbreviation | Disease(s) protected against | Age due |
---|---|---|
Zostavax (MSD) [Shingrix (GSK) – only for those contra-indicated to Zostavax] Shingles | Shingles | 70 years |
Images of inactivated influenza vaccines are not shown as several different products are available.
Full details of the routine immunisation schedule are available
-
See annual flu letter for eligible age groups ↩
-
See the Green Book ↩